Synthesis, antimicrobial and antioxidant activities of 2-[1-{3,5-diaryl-4,5-dihydro-1H-pyrazolenyl}]-4-(4-nitrophenyl)-[1,3]-thiazoles

[1]  P. L. Lobo,et al.  Synthesis of Some Fused Triazole Derivatives Containing 4-Isobutylphenylethyl and 4-Methylthiophenyl Moieties , 2010 .

[2]  P. L. Lobo,et al.  Synthesis and Antimicrobial Evaluation of Some New 2-(6-Oxo-5,6-dihydro[1,3]thiazolo [3,2-b]-2-aryloxymethyl-1,2,4-triazol-5-yl)-N-arylacetamides. , 2010 .

[3]  N. S. Rai,et al.  Convenient access to 1,3,4-trisubstituted pyrazoles carrying 5-nitrothiophene moiety via 1,3-dipolar cycloaddition of sydnones with acetylenic ketones and their antimicrobial evaluation. , 2008, European journal of medicinal chemistry.

[4]  Y. Naito,et al.  The radical scavenger edaravone enhances the anti-tumor effects of CPT-11 in murine colon cancer by increasing apoptosis via inhibition of NF-kappaB. , 2005, Cancer letters.

[5]  B. Poojary,et al.  A Novel Three-Component Synthesis of Triazinothiazolones. , 2005 .

[6]  H. Eraksoy,et al.  Comparative Activities of β-Lactam Antibiotics and Quinolones for Invasive Streptococcus pneumoniae Isolates , 2004, Chemotherapy.

[7]  S. Sakya,et al.  Efficient Synthesis of 5‐Alkyl Amino and Thioether Substituted Pyrazoles. , 2004 .

[8]  Jae Nyoung Kim,et al.  Regioselective Synthesis of 1,3,4,5-Tetrasubstituted Pyrazoles from Baylis—Hillman Adducts. , 2003 .

[9]  Jae Nyoung Kim,et al.  Regioselective synthesis of 1,3,4,5-tetrasubstituted pyrazoles from Baylis–Hillman adducts , 2003 .

[10]  J. N. Low,et al.  Control of the reaction between 2-aminobenzothiazoles and Mannich bases. Synthesis of pyrido[2,1-b][1,3]benzothiazoles versus [1,3]benzothiazolo[2,3-b]quinazolines , 2002 .

[11]  I. Charles,et al.  Synthesis and biological evaluation of novel pyrazoles and indazoles as activators of the nitric oxide receptor, soluble guanylate cyclase. , 2001, Journal of medicinal chemistry.

[12]  D. Erol,et al.  Synthesis and antidepressant activities of some 3,5-diphenyl-2-pyrazolines. , 2001, European journal of medicinal chemistry.

[13]  B. Arthington-Skaggs,et al.  Comparative evaluation of PASCO and national committee for clinical laboratory standards M27-A broth microdilution methods for antifungal drug susceptibility testing of yeasts. , 2000, Journal of clinical microbiology.

[14]  C. Koboldt,et al.  Synthesis and activity of sulfonamide-substituted 4,5-diaryl thiazoles as selective cyclooxygenase-2 inhibitors. , 1999, Bioorganic & medicinal chemistry letters.

[15]  A. Tamura,et al.  Cerebroprotective effects of a novel pyrazoline derivative, MS-153, on focal ischemia in rats. , 1997, Japanese journal of pharmacology.

[16]  A. Markham,et al.  Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability. , 1996, Drugs.

[17]  J M Morin,et al.  Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relationship studies of PETT analogs. , 1995, Journal of medicinal chemistry.

[18]  C. J. Dunn,et al.  Pyrazoline bisphosphonate esters as novel antiinflammatory and antiarthritic agents. , 1993, Journal of medicinal chemistry.

[19]  A. Doherty,et al.  Structure-activity relationships of a series of 2-amino-4-thiazole-containing renin inhibitors. , 1992, Journal of medicinal chemistry.

[20]  T. Heffner,et al.  4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines: a novel class of compounds with central dopamine agonist properties. , 1990, Journal of medicinal chemistry.

[21]  K. D. Hargrave,et al.  N-(4-SUBSTITUTED-THIAZOLYL)OXAMIC ACID DERIVATIVES, NEW SERIES OF POTENT, ORALLY ACTIVE ANTIALLERGY AGENTS , 1983 .